Skip to main content
. 2022 Feb 25;30(9):1060–1066. doi: 10.1038/s41431-022-01049-2

Fig. 1. Metastasis-free survival by screening group.

Fig. 1

Metastasis-free survival was compared in the two groups: IBPG (incident breast cancer group) and the PBCG (prevalent breast cancer group). Metastasis-free survival was defined as time from histological diagnosis to breast cancer-specific metastasis or death, whichever occurred first. Differences in breast cancer-specific metastasis-free survival were compared in log-rank tests. Red: IBCG group (103 women, 6 with metastasis or death). Blue: PBCG group (417 women, 82 with metastasis or death). ***p < 0.0001, ****p < 0.00001.